Atlas Trials

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

Clinical trial NCT06766591 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06766591
Sponsor
Jiangsu Province Nanjing Brain Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
NSCLCChemotherapyLeptomeningeal MetastasesEGFR-TKIAK112
Start date
2025-01-01
Primary completion
2025-10-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.